Dr Yiping Chen
Senior Research Fellow
Yiping Chen is a senior research fellow at the CTSU, University of Oxford. She qualified in clinical medicine in 1985 at Shanghai Medical University (now Fudan University) and then worked as junior neurologist in University affiliated teaching hospital, Hua-shan hospital in Shanghai. In 1988 she was awarded Sino-British Friendship Scholarship to study in the UK and gained her PhD at the University of Oxford in 1993.
She joined CTSU in 1998 and has worked as study coordinator and senior research fellow in several CTSU-led large clinical trials such as COMMIT/CCS2, SHARP, HPS2-THRIVE, REVEAL. During 2006-2016 she also plays a leading role in running Oxford-China Fellowship programmes which provides residence training in epidemiology, medical statistics and clinical trials methodology for the clinical doctors, public health workers from China.
She is currently leading a multi-disciplinary team in the China Kadoorie Biobank (CKB) of 0.5 million people, responsible for developing strategies and procedures related to validation of electronically reported clinical events and for conducting disease validation and adjudication in collaboration with clinical specialists in China for CKB. Her main research interests are in the fields of clinical epidemiology of cardiovascular diseases, major depression, and sleeping disorders
Natural history of silent lacunar infarction: 10-year follow-up of a community-based prospective study of 0.5 million Chinese adults.
Hao Z. et al, (2021), Lancet Reg Health West Pac, 17
The Genetic Architecture of Depression in Individuals of East Asian Ancestry: A Genome-Wide Association Study.
Giannakopoulou O. et al, (2021), JAMA Psychiatry
Alcohol drinking and risks of liver cancer and non-neoplastic chronic liver diseases in China: a 10-year prospective study of 0.5 million adults.
Im PK. et al, (2021), BMC Med, 19
Epigenome-wide analysis of DNA methylation and coronary heart disease: a nested case-control study.
Si J. et al, (2021), Elife, 10
Dietary patterns and cardiometabolic diseases in 0.5 million Chinese adults: a 10-year cohort study.
Qin C. et al, (2021), Nutr J, 20